Recent advances in managing triple-negative breast cancers

Triple-negative breast cancer (TNBC) has been recently recognized as an important subgroup of breast cancer with a distinct outcome and therapeutic approach compared with other breast cancer subgroups. Because TNBC is defined by the absence of a target (either hormone receptors or HER-2), convention...

Descripción completa

Detalles Bibliográficos
Autor principal: Bengala, Carmelo
Formato: Texto
Lenguaje:English
Publicado: Medicine Reports Ltd 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948296/
https://www.ncbi.nlm.nih.gov/pubmed/20948704
http://dx.doi.org/10.3410/M1-75
_version_ 1782187439967698944
author Bengala, Carmelo
author_facet Bengala, Carmelo
author_sort Bengala, Carmelo
collection PubMed
description Triple-negative breast cancer (TNBC) has been recently recognized as an important subgroup of breast cancer with a distinct outcome and therapeutic approach compared with other breast cancer subgroups. Because TNBC is defined by the absence of a target (either hormone receptors or HER-2), conventional cytotoxic therapy is still the mainstay of treatment. This report focuses on the current state and recent advances in managing TNBC.
format Text
id pubmed-2948296
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medicine Reports Ltd
record_format MEDLINE/PubMed
spelling pubmed-29482962010-10-14 Recent advances in managing triple-negative breast cancers Bengala, Carmelo F1000 Med Rep Review Article Triple-negative breast cancer (TNBC) has been recently recognized as an important subgroup of breast cancer with a distinct outcome and therapeutic approach compared with other breast cancer subgroups. Because TNBC is defined by the absence of a target (either hormone receptors or HER-2), conventional cytotoxic therapy is still the mainstay of treatment. This report focuses on the current state and recent advances in managing TNBC. Medicine Reports Ltd 2009-09-28 /pmc/articles/PMC2948296/ /pubmed/20948704 http://dx.doi.org/10.3410/M1-75 Text en © 2009 Medicine Reports Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Bengala, Carmelo
Recent advances in managing triple-negative breast cancers
title Recent advances in managing triple-negative breast cancers
title_full Recent advances in managing triple-negative breast cancers
title_fullStr Recent advances in managing triple-negative breast cancers
title_full_unstemmed Recent advances in managing triple-negative breast cancers
title_short Recent advances in managing triple-negative breast cancers
title_sort recent advances in managing triple-negative breast cancers
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948296/
https://www.ncbi.nlm.nih.gov/pubmed/20948704
http://dx.doi.org/10.3410/M1-75
work_keys_str_mv AT bengalacarmelo recentadvancesinmanagingtriplenegativebreastcancers

Ejemplares similares